Expression of MDM2 during mammary tumorigenesis

International Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 292-298

  Pinkas, Jan ^a   Naber, Stephen P ^b   Butel, Janet S ^c   Medina, Daniel ^c   Jerry, D Joseph ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; CARBOXY TERMINAL SEQUENCE; EXON; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ALTERNATIVE SPLICING; ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC CODE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032911238     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990412)81:2<292::AID-IJC20>3.0.CO;2-I     Document Type: Article

References (22)

1. ALLRED, D.C., CLARK, G.M., ELLEDGE, R., FUQUA, S.A.W., BROWN, R.W., CHAMNESS, G.C., OSBORNE, C.K. and MCGUIRE, W.L., Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. nat. Cancer Instit., 85, 200-206 (1993).
2. BARAK, Y., GOTTLIEB, E., JUVEN-GERSHON, T. and OREN, M., Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Develop., 8, 1739-1749 (1994).
3. BUESO-RAMOS, C.E., MANSHOURI, T., HAIDAR, M.A., YANG, Y., MCCOWAN, P., ORDONEZ, N., GLASSMAN, A., SNEIGE, N. and ALBITAR, M., Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res. Treat., 37, 179-188 (1996).
4. 1 cell-cycle arrest. Oncongene, 11, 2445-2449 (1995).
5. ERHARDT, P., TOMASELLI, K.J. and COOPER, G.M., Identification of the MDM2 oncoprotein as a substrate for CPP32-like apoplotic proteases. J. biol. Chem., 272, 15049-15052 (1997).
6. FAKHARZADEH, S.S., TRUSKO, S.P. and GEORGE, D.L., Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J., 10, 1565-1569 (1991).
7. GORGOULIS, V.G., ZOUMPOURLIS, V., RASSIDAKIS, G.Z., KARAMERIS, A., RASSIDAKIS, A.N., SPANDIDOS, D.A. and KITTAS, C., A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma. J. Pathol., 180, 129-137 (1996).
8. GUDAS, J.M., NGUYEN, H., KLEIN, R.C., KATAYOSE, D., SETH, P. and COWAN, K.H., Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res., 1, 71-80 (1995).
9. HAUPT, Y., MAYA, R., KAZAZ, A. and OREN, M., Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387, 296-299 (1997).
10. HONDA, R., TANAKA, H. and YASUDA, H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett., 420, 25-27 (1997).
11. JERRY, D.J., BUTEL, J.S., DONEHOWER, L.A., PAULSON, E.J., COCHRAN, C., WISEMAN, R.W. and MEDINA, D., Infrequent p53 mutations in 7,12-dimetriylbenz[a]anthracene-induced mammary tumors in Balb/c and p53 hemizygous mice. Mol. Carcinogenesis, 9, 175-183 (1994).
12. JONES, S.N., ANSARI-LARI, M.A., HANCOCK, A.R., JONES, W.J., GIBBS, R.A., DONEHOWER, L.A. and BRADLEY, A., Genomic organization of the mouse double minute 2 gene. Gene, 175, 209-213 (1996).
13. LUNDGREN, K., DE OCA LUNA, R.M., MCNEILL, Y.B., EMERICK, E.P., SPENCER, B., BARFIELD, C.R., LOZANO, G., ROSENBERG, M.P. and FINLAY. C.A., Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Develop., 11, 714-725 (1997).
14. MCCANN, A.H., KIRLEY, A., CARNEY, D.N., CORBALLY, N., MAGEE, H.M., KEATING, G. and DERVAN, P.A., Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Brit. J. Cancer, 71, 981-985 (1995).
15. MEDINA, D., The mammary gland: a unique organ for the study of development and tumorigenesis. J. Mam. Gland Bio. Neo., 1, 5-19 (1996).
16. MOLL, U.M., RIOU, G. and LEVISE, A.J., Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. nat. Acad. Sci. (Wash.), 89, 7262-7266 (1992).
17. MOMAND, J., JUNG, D., WILCZYNSKI, S. and NILAND, J., The MDM2 gene amplification database. Nucl. Acids Res., 26, 3453-3459 (1998).
18. MOMAND, J., ZAMBETI, G.P., OLSON, D.C., GEORGE, D.L. and LEVINE, A.J., The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245 (1992).
19. MOMAND, J. and ZAMBETTI, G.P., Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics. Oncogene, 12, 2279-2289 (1996).
20. PIETTE, J., NEEL, H. and MARECHAL, V., Mdm2: keeping p53 under control Oncogene, 15, 1001-1010 (1997).
21. SIGALAS, I., CALVERT, A.H., ANDERSEN, J.J., NEAL, D.E. and LUNEC, J., Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer. Nature (Med.), 2, 912-917 (1996).
22. ZAUBERMAN, A., FLUSBERG, D., HAUPT, Y., BARAK, Y. and OREN, M., A functional p53 responsive intronic promoter is contained within the human mdm2 gene. Nucl. Acids Res., 23, 2584-2592 (1995).